187 related articles for article (PubMed ID: 33866550)
1. 16α-Bromoepiandrosterone as a new candidate for experimental diabetes-tuberculosis co-morbidity treatment.
López-Torres MO; Marquina-Castillo B; Ramos-Espinosa O; Mata-Espinosa D; Barrios-Payan JA; Baay-Guzman G; Yepez SH; Bini E; Torre-Villalvazo I; Torres N; Tovar A; Chamberlin W; Ge Y; Carranza A; Hernández-Pando R
Clin Exp Immunol; 2021 Aug; 205(2):232-245. PubMed ID: 33866550
[TBL] [Abstract][Full Text] [Related]
2. Structural homology between 11 beta-hydroxysteroid dehydrogenase and
Hernández-Bustamante I; Santander-Plantamura Y; Mata-Espinosa D; Reyes-Chaparro A; Bini EI; Torre-Villalvazo I; Tovar AR; Barrios-Payan J; Marquina-Castillo B; Hernández-Pando R; Carranza A
Front Endocrinol (Lausanne); 2022; 13():1055430. PubMed ID: 36699022
[TBL] [Abstract][Full Text] [Related]
3. Mucosal delivery of ESX-1-expressing BCG strains provides superior immunity against tuberculosis in murine type 2 diabetes.
Sathkumara HD; Muruganandah V; Cooper MM; Field MA; Alim MA; Brosch R; Ketheesan N; Govan B; Rush CM; Henning L; Kupz A
Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20848-20859. PubMed ID: 32778586
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a More Disrupted Immune-Endocrine Relation and Cortisol Immunologic Influences in the Context of Tuberculosis and Type 2 Diabetes Comorbidity.
Fernández RDV; Díaz A; Bongiovanni B; Gallucci G; Bértola D; Gardeñez W; Lioi S; Bertolin Y; Galliano R; Bay ML; Bottasso O; D'Attilio L
Front Endocrinol (Lausanne); 2020; 11():126. PubMed ID: 32265833
[TBL] [Abstract][Full Text] [Related]
5. A murine model of tuberculosis/type 2 diabetes comorbidity for investigating the microbiome, metabolome and associated immune parameters.
Sathkumara HD; Eaton JL; Field MA; Govan BL; Ketheesan N; Kupz A
Animal Model Exp Med; 2021 Jun; 4(2):181-188. PubMed ID: 34179725
[TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
7. Increased susceptibility to Mycobacterium tuberculosis infection in a diet-induced murine model of type 2 diabetes.
Alim MA; Kupz A; Sikder S; Rush C; Govan B; Ketheesan N
Microbes Infect; 2020 Sep; 22(8):303-311. PubMed ID: 32234542
[TBL] [Abstract][Full Text] [Related]
8. Effect of Curcumin in Experimental Pulmonary Tuberculosis: Antimycobacterial Activity in the Lungs and Anti-Inflammatory Effect in the Brain.
Lara-Espinosa JV; Arce-Aceves MF; López-Torres MO; Lozano-Ordaz V; Mata-Espinosa D; Barrios-Payán J; Silva-Islas CA; Maldonado PD; Marquina-Castillo B; Hernández-Pando R
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216083
[TBL] [Abstract][Full Text] [Related]
9. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
10. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
[TBL] [Abstract][Full Text] [Related]
11. Immunoendocrine abnormalities in the male reproductive system during experimental pulmonary tuberculosis.
Ramos Robles B; Valdez RA; Hernández UJ; Marquina Castillo B; Mata Espinosa D; Barrios Payan J; Hernández Pando R; Romano MC
Tuberculosis (Edinb); 2018 Mar; 109():109-116. PubMed ID: 29559114
[TBL] [Abstract][Full Text] [Related]
12. Immune variations throughout the course of tuberculosis treatment and its relationship with adrenal hormone changes in HIV-1 patients co-infected with Mycobacterium tuberculosis.
Vecchione MB; Angerami MT; Suarez GV; Turk G; Laufer N; Ben G; Ameri D; Gonzalez D; Parodi LM; Giavedoni LD; Maidana P; Fabre B; Mesch V; Sued O; Quiroga MF
Tuberculosis (Edinb); 2021 Mar; 127():102045. PubMed ID: 33434785
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of liposomes containing 4-(5-pentadecyl-1,3,4-oxadiazol-2-yl)pyridine in a murine model of progressive pulmonary tuberculosis.
Mata-Espinosa D; Molina-Salinas GM; Barrios-Payán J; Navarrete-Vázquez G; Marquina B; Ramos-Espinosa O; Bini EI; Baeza I; Hernández-Pando R
Pulm Pharmacol Ther; 2015 Jun; 32():7-14. PubMed ID: 25843004
[TBL] [Abstract][Full Text] [Related]
14. 16alpha-Bromoepiandrosterone restores T helper cell type 1 activity and accelerates chemotherapy-induced bacterial clearance in a model of progressive pulmonary tuberculosis.
Hernández-Pando R; Aguilar-Leon D; Orozco H; Serrano A; Ahlem C; Trauger R; Schramm B; Reading C; Frincke J; Rook GA
J Infect Dis; 2005 Jan; 191(2):299-306. PubMed ID: 15609241
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected mice.
Koo MS; Manca C; Yang G; O'Brien P; Sung N; Tsenova L; Subbian S; Fallows D; Muller G; Ehrt S; Kaplan G
PLoS One; 2011 Feb; 6(2):e17091. PubMed ID: 21364878
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoids inhibit interconversion of 7-hydroxy and 7-oxo metabolites of dehydroepiandrosterone: a role for 11beta-hydroxysteroid dehydrogenases?
Robinzon B; Michael KK; Ripp SL; Winters SJ; Prough RA
Arch Biochem Biophys; 2003 Apr; 412(2):251-8. PubMed ID: 12667489
[TBL] [Abstract][Full Text] [Related]
17. Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection.
O'Connor G; Krishnan N; Fagan-Murphy A; Cassidy J; O'Leary S; Robertson BD; Keane J; O'Sullivan MP; Cryan SA
Eur J Pharm Biopharm; 2019 Jan; 134():153-165. PubMed ID: 30385419
[TBL] [Abstract][Full Text] [Related]
18. Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs.
Clemens DL; Lee BY; Silva A; Dillon BJ; Masleša-Galić S; Nava S; Ding X; Ho CM; Horwitz MA
PLoS One; 2019; 14(5):e0215607. PubMed ID: 31075149
[TBL] [Abstract][Full Text] [Related]
19. Effects of glycyrrhizic acid on 11 β-hydroxysteroid dehydrogenase (11 βHSD1 and 2) activities and HOMA-IR in rats at different treatment periods.
Chia YY; Ton SH; Kadir KB
Exp Clin Endocrinol Diabetes; 2010 Oct; 118(9):617-24. PubMed ID: 19998240
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
